Diebold Nixdorf, Incorporated

Informe acción SWX:WIN

Capitalización de mercado: CHF1.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Salud financiera de hoja de balance de Diebold Nixdorf

Salud financiera controles de criterios 1/6

Diebold Nixdorf has a total shareholder equity of $-2.1B and total debt of $1.3B, which brings its debt-to-equity ratio to -59%. Its total assets and total liabilities are $3.4B and $5.5B respectively. Diebold Nixdorf's EBIT is $84.2M making its interest coverage ratio 0.4. It has cash and short-term investments of $552.8M.

Información clave

-59.0%

Ratio deuda-patrimonio

US$1.26b

Deuda

Ratio de cobertura de intereses0.4x
EfectivoUS$552.80m
Patrimonio-US$2.13b
Total pasivoUS$5.54b
Activos totalesUS$3.41b

Actualizaciones recientes sobre salud financiera

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: WIN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Pasivo a largo plazo: WIN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: WIN has negative shareholder equity, which is a more serious situation than a high debt level.

Reducción de la deuda: WIN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: WIN has sufficient cash runway for more than a year based on its current free cash flow.

Pronóstico de cash runway: Insufficient data to determine if WIN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target